4-Phenylureido/thioureido-substituted 2,2-dimethylchroman analogs of cromakalim bearing a bulky 'carbamate' moiety at the 6-position as potent inhibitors of glucose-sensitive insulin secretion
Pirotte, Bernard; Florence, X; Goffin, Ericet al.
2016 • In European Journal of Medicinal Chemistry, 121, p. 338-351
Pirotte, Bernard ; Université de Liège > Département de pharmacie > Chimie pharmaceutique
Florence, X
Goffin, Eric ; Université de Liège > Département de pharmacie > Chimie pharmaceutique
Medeiros, MB
De Tullio, Pascal ; Université de Liège > Département de pharmacie > Chimie pharmaceutique
Lebrun, P
Language :
English
Title :
4-Phenylureido/thioureido-substituted 2,2-dimethylchroman analogs of cromakalim bearing a bulky 'carbamate' moiety at the 6-position as potent inhibitors of glucose-sensitive insulin secretion
M.A. Burke, R.K. Mutharasan, H. Ardehali, The sulfonylurea receptor, anatypical ATP-binding cassette protein, and its regulation of the KATP channel,Circ. Res. 102 (2008) 164-176.
C.G. Nichols, KATP channels as molecular sensors of cellular metabolism, Nature440 (2006) 470-476.
N. Inagaki, S. Seino, ATP-sensitive potassium channels: structures, functions,and pathophysiology, Jpn. J. Physiol. 48 (1998) 397-412.
A. Tinker, Q. Aziz, A. Thomas, The role of ATP-sensitive potassium channels incellular function and protection in the cardiovascular system, Br. J. Pharmacol.171 (2014) 12-23.
S. Seino, ATP-sensitive potassium channels: a model of heteromultimericpotassium channel/receptor assemblies, Annu. Rev. Physiol. 61 (1999)337-362.
D. Tricarico, A. Mele, A.L. Lundquist, R.R. Desai, A.L. George, D.C. Camerino,Hybrid assemblies of ATP-sensitive K\+ channels determine their muscle-typedependentbiophysical and pharmacological properties, Proc. Natl. Acad. Sci.U. S. A. 103 (2006) 1118-1123.
N.-Q. Shi, B. Ye, J.C. Makielski, Function and distribution of the SUR isoformsand splice variants, J. Mol. Cell. Cardiol. 39 (2005) 51-60.
S. Seino, H. Takahashi, T. Takahashi, T. Shibasaki, Treating diabetes today: amatter of selectivity of sulphonylureas, Diabetes Obes. Metab. 14 (2012)9e13.
A. Jahangir, A. Terzic, KATP channel therapeutics at the bedside, J. Mol. Cell.Cardiol. 39 (2005) 99-112.
P. De Tullio, P. Lebrun, X. Florence, P. Francotte, B. Pirotte, Selective pancreaticATP-sensitive potassium channel openers for the treatment of glucose homeostasisdisorders, Drug Future 31 (2006) 991-1001.
S. Seino, T. Miki, Physiological and pathophysiological roles of ATP-sensitiveK\+ channels, Prog. Biophys. Mol. Biol. 81 (2003) 133-176.
P. Lebrun, V. Devreux, M. Hermann, A. Herchuelz, Similarities between theeffects of pinacidil and diazoxide on ionic and secretory events in ratpancreatic islets, J. Phamacol. Exp. Ther. 250 (1989) 1011-1018.
F.M. Gribble, S.J. Tucker, F.M. Ashcroft, The essential role of the walker a motifsof SUR1 in K-ATP channel activation by Mg-ADP and diazoxide, EMBO J. 16(1997) 1145-1152.
K. Masuzawa, M. Asano, T. Matsuda, Y. Imaizumi, M. Watanabe, Comparison ofeffects of cromakalim and pinacidil on mechanical activity and 86Rb efflux indog coronary arteries, J. Pharmacol. Exp. Ther. 253 (1990) 586-593.
A. Tabarin, B. Goichot, Treatment: symptomatic treatment of hypoglycaemia,Ann. Endocrinol. (Paris) 74 (2013) 196-199.
T. Yorifuji, Congenital hyperinsulinism: current status and future perspectives,Ann. Pediatr. Endocrinol. Metab. 19 (2014) 57-68.
M. Dabrowski, F.M. Ashcroft, R. Ashfield, P. Lebrun, B. Pirotte, J. Egebjerg,J. Bondo Hansen, P. Wahl, The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1channel opener, Diabetes 51 (2002) 1896-1906.
B. Pirotte, M.-H. Antoine, P. de Tullio, M. Hermann, A. Herchuelz, J. Delarge,P. Lebrun, A pyridothiadiazine (BPDZ 44) as a new and potent activator ofATP-sensitive K\+ channels, Biochem. Pharmacol. 47 (1994) 1381-1386.
R.D. Carr, C.L. Brand, T.B. Bodvarsdottir, J.B. Hansen, J. Sturis, NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improvesglucose tolerance in the VDF zucker rat, Diabetes 52 (2003)2513-2518.
R. Raphemot, D.R. Swale, P.K. Dadi, D.A. Jacobson, P. Cooper, A.P. Wojtovich,S. Banerjee, C.G. Nichols, J.S. Denton, Direct activation of b-cell KATP channelswith a novel xanthine derivative, Mol. Pharmacol. 85 (2014) 858-865.
S. Sebille, D. Gall, P. de Tullio, X. Florence, P. Lebrun, B. Pirotte, Design, synthesisand pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: towards tissueselectivepancreatic B-cells KATP channel openers structurally related to(±)-cromakalim, J. Med. Chem. 49 (2006) 4690-4697.
S. Sebille, P. de Tullio, X. Florence, B. Becker, M.-H. Antoine, C. Michaux,J. Wouters, B. Pirotte, P. Lebrun, New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to(\+/-)-cromakalim as tissue-selective pancreatic beta-cell KATP channelopeners, Bioorg. Med. Chem. 16 (2008) 5704-5719.
X. Florence, S. Sebille, P. de Tullio, P. Lebrun, B. Pirotte, New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as KATP channel openers: modulation of the4-Position, Bioorg. Med. Chem. 17 (2009) 7723-7731.
X. Florence, S. Dilly, P. de Tullio, B. Pirotte, P. Lebrun, Modulation of the 6-position of benzopyran derivatives and inhibitory effects on the insulinreleasing process, Bioorg. Med. Chem. 19 (2011) 3919-3928.
P. Lebrun, P. Arkhammar, M.-H. Antoine, Q.-A. Nguyen, J.B. Hansen, B. Pirotte,A potent diazoxide analogue activating ATP-sensitive K\+ channels andinhibiting insulin release, Diabetologia 43 (2000) 723-732.
A. Ramnathan, K. Sivakumar, K. Subramanian, N. Janarthanan, K. Ramadas, H.-K. Fun, Symmetrically substituted thiourea derivatives, Acta Cryst. C51 (1995)2446-2450.
Dinesh Rajnikant, M.B. Deshmukh, Kamni, Synthesis, X-ray structure and NH.O interactions in 1,3-diphenyl-urea, Bull. Mater. Sci. 29 (2006) 239-242.
L. Checinska, W. Morgenroth, C. Paulmann, D. Jayatilaka, B. Dittrich,A comparison of electron density from Hirshfeld-atom refinement, X-raywavefunction refinement and multipole refinement on three urea derivatives,Cryst. Eng. Commun. 15 (2013) 2084-2090.
A. Okuniewski, J. Chojnacki, B. Becker, N,N0-Diphenylthiourea acetone monosolvate,Acta Cryst. E67 (2011) o55.
U. Quast, N.S. Cook, In vitro and in vivo comparison of two K\+ channelopeners, diazoxide and cromakalim, and their inhibition by glibenclamide,J. Pharmacol. Exp. Ther. 250 (1989) 261-271.
P. Lebrun, B. Becker, N. Morel, P. Ghisdal, M.-H. Antoine, P. de Tullio, B. Pirotte,KATP channel openers: tissue selectivity of original 3-alkylaminopyrido-and3-alkylaminobenzothiadiazine 1,1-dioxides, Biochem. Pharmacol. 75 (2008)468-475.
B. Pirotte, P. de Tullio, S. Boverie, C. Michaux, P. Lebrun, Impact of the nature ofthe substituent at the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides ontheir opening activity toward ATP-sensitive potassium channels, J. Med.Chem. 54 (2011) 3188-3199.
M.-H. Antoine, M. Hermann, A. Herchuelz, P. Lebrun, Ionic and secretoryresponse of pancreatic islet cells to minoxidil sulfate, J. Pharmacol. Exp. Ther.258 (1991) 286-291.
T. Tagmose, S.C. Schou, J.P. Mogensen, F.E. Nielsen, P.O.G. Arkhammar, P. Wahl,B.S. Hansen, A. Worsaae, H.C.M. Boonen, M.-H. Antoine, P. Lebrun, J. BondoHansen, Arylcyanoguanidines as activators of Kir6.2/SUR1 KATP channels andinhibitors of insulin release, J. Med. Chem. 47 (2004) 3202-3211.
B. Becker, M.-H. Antoine, Q.-A. Nguyen, B. Rigo, K.E. Cosgrove, P.D. Barnes,M.J. Dunne, B. Pirotte, P. Lebrun, Synthesis and characterization of a quinolinoniccompound activating ATP-sensitive K\+ channels in endocrine andsmooth muscle tissues, Br. J. Pharmacol. 134 (2001) 375-385.
X. Florence, V. Desvaux, E. Goffin, P. de Tullio, B. Pirotte, P. Lebrun, Influence ofthe alkylsulfonylamino substituent located at the 6-position of 2,2-dimethylchromans structurally related to cromakalim: from potassiumchannel openers to calcium entry blockers? Eur. J. Med. Chem. 80 (2014)36-46.
B. Pirotte, P. de Tullio, S. Boverie, C. Michaux, P. Lebrun, Impact of the nature ofthe substituent at the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides ontheir opening activity toward ATP-sensitive potassium channels, J. Med.Chem. 54 (2011) 3188-3199.
